Manufacturer record
Abaris Healthcare Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Abaris Healthcare Pvt. Ltd (Gujarat) were declared Not of Standard Quality between September 2019 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Abaris Healthcare Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Promethazine Hydrochloride Injection IP 25mg/ml | AHL0107Mfg 2025-08 · Exp 2027-07 | The sample does not conform to IP with respect to the Test of Particulate matter and Description.Description | CDL, KolkataCDSCO lab | Feb 2026 |
| Linezolid IV Injection 600 mg/ 300 ml (ABAZOLID) | A4544004Mfg 2024-04 · Exp 2026-03 | "Related substances"Related substances | CDTL MumbaiCDSCO lab | Feb 2025 |
| INFI-650 TABLETS (PARACETAMOL TABLETS I.P. 650 mg) | AT-100008Mfg 2022-12 · Exp 2025-11 | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST.Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| MULTIELECTROLYTE WITH 20% w/v DEXTROSE INJECTION (INTALYTE (Veterinary) | IN703401 1Mfg 2023-03 · Exp 2026-02 | Particulate Contamination, Sterility and DescriptionDescription | RDTL GuwahatiState lab | Jul 2023 |
| Amiject 500 (Amikacin Sulphate Injection I.P.) | L079018Mfg 2019-04 · Exp 2021-03 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Sep 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.